Passage Bio, Inc. (PASG) Tops Q3 EPS by 29c

Passage Bio, Inc. (NASDAQ: PASG) reported Q3 EPS of ($0.49), $0.29 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'
• Goldman "broadly" raises estimates for LTL and truckload stocks